Evaluation and treatment of dyslipidemia (high cholesterol) has been totally mis-directed in the last 30-40 years. It’s hard to believe, isn’t it? The problem is not that we don’t have great doctors treating patients, it’s really because medicine is not keeping up with the latest research, unless it comes from a pharmaceutical company’s clinical trials. We now have at our fingertips, a new and revolutionary approach to treating dyslipidemia. It’s important to first understand what it is and how it is caused.
Dyslipidemia: Our Mis-Directed Treatment Efforts
